These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15050857)

  • 1. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus.
    Kaidanovich-Beilin O; Milman A; Weizman A; Pick CG; Eldar-Finkelman H
    Biol Psychiatry; 2004 Apr; 55(8):781-4. PubMed ID: 15050857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.
    Kaidanovich-Beilin O; Eldar-Finkelman H
    J Pharmacol Exp Ther; 2006 Jan; 316(1):17-24. PubMed ID: 16169938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum.
    Alimohamad H; Rajakumar N; Seah YH; Rushlow W
    Biol Psychiatry; 2005 Mar; 57(5):533-42. PubMed ID: 15737669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.
    Duman CH; Schlesinger L; Kodama M; Russell DS; Duman RS
    Biol Psychiatry; 2007 Mar; 61(5):661-70. PubMed ID: 16945347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3.
    Plotkin B; Kaidanovich O; Talior I; Eldar-Finkelman H
    J Pharmacol Exp Ther; 2003 Jun; 305(3):974-80. PubMed ID: 12626660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test.
    Galeotti N; Bartolini A; Ghelardini C
    Neuropharmacology; 2006 Mar; 50(3):309-16. PubMed ID: 16249008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus.
    Cardona-Gomez P; Perez M; Avila J; Garcia-Segura LM; Wandosell F
    Mol Cell Neurosci; 2004 Mar; 25(3):363-73. PubMed ID: 15033165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test.
    Ghasemi M; Sadeghipour H; Mosleh A; Sadeghipour HR; Mani AR; Dehpour AR
    Eur Neuropsychopharmacol; 2008 May; 18(5):323-32. PubMed ID: 17728109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test.
    Jesse CR; Bortolatto CF; Savegnago L; Rocha JB; Nogueira CW
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1838-43. PubMed ID: 18773934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle.
    Ryves WJ; Harwood AJ
    Prog Cell Cycle Res; 2003; 5():489-95. PubMed ID: 14593744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization.
    Lamarre M; Desrosiers RR
    Neuropharmacology; 2008 Oct; 55(5):669-76. PubMed ID: 18582478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injury.
    Shapira M; Licht A; Milman A; Pick CG; Shohami E; Eldar-Finkelman H
    Mol Cell Neurosci; 2007 Apr; 34(4):571-7. PubMed ID: 17289399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth.
    Mazor M; Kawano Y; Zhu H; Waxman J; Kypta RM
    Oncogene; 2004 Oct; 23(47):7882-92. PubMed ID: 15361837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
    Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice.
    Tanaka M; Telegdy G
    Brain Res Bull; 2008 Mar; 75(5):509-12. PubMed ID: 18355626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats.
    Tamburella A; Micale V; Navarria A; Drago F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1205-10. PubMed ID: 19596038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming test.
    Kaster MP; Budni J; Binfaré RW; Santos AR; Rodrigues AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):690-6. PubMed ID: 17296254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine up-regulates a cluster of intronic miRNAs within the serotonin receptor 2C gene by inhibiting glycogen synthase kinase-3.
    Grieco SF; Velmeshev D; Magistri M; Eldar-Finkelman H; Faghihi MA; Jope RS; Beurel E
    World J Biol Psychiatry; 2017 Sep; 18(6):445-456. PubMed ID: 27723376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of various classes of antidepressants in behavioral paradigms of despair.
    Kulkarni SK; Dhir A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1248-54. PubMed ID: 17570574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3.
    Gould TD; Chen G; Manji HK
    Neuropsychopharmacology; 2004 Jan; 29(1):32-8. PubMed ID: 12942141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.